Runben Biotechnology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	1,246	1,032	855.65	581.91	442.66	278.48
Other Revenue	0.66	0.66	0.44	0.24	0.17	0.16
Revenue	1,247	1,033	856.09	582.15	442.83	278.64
Revenue Growth (YoY)	24.89%	20.66%	47.06%	31.46%	58.93%	-
Cost of Revenue	524.22	453.34	393.28	275.75	210.99	129.71
Gross Profit	722.73	579.62	462.81	306.4	231.83	148.92
Selling, General & Admin	377.07	301.68	257.21	155.39	109.8	90.96
Research & Development	32.05	25.69	19.51	13.6	10.71	7.81
Other Operating Expenses	12.86	9.42	8.77	6.83	4.46	3.35
Operating Expenses	422.39	336.99	285.47	175.82	125	102.23
Operating Income	300.33	242.62	177.34	130.58	106.84	46.7
Interest Expense	-0.16	-0.26	-0.43	-0.54	-	-
Interest & Investment Income	43.23	16.4	7.18	6.09	0.8	0.32
Currency Exchange Gain (Loss)	-	-	-	0.24	-	-
Other Non Operating Income (Expenses)	4.63	-0.05	-0.16	-0.05	-0.03	-1.82
EBT Excluding Unusual Items	348.03	258.72	183.94	136.32	107.61	45.19
Gain (Loss) on Sale of Investments	-	-	-	-	0.36	-
Gain (Loss) on Sale of Assets	-0.25	0.07	0.05	0	-	-
Asset Writedown	-2.15	-	-	-	-	-4.4
Other Unusual Items	9.13	9.13	4.29	5.31	2.28	0.95
Pretax Income	354.77	267.93	188.27	141.63	110.24	41.74
Income Tax Expense	48.59	41.9	28.23	20.98	15.53	6.07
Net Income	306.18	226.03	160.04	120.65	94.71	35.67
Net Income to Common	306.18	226.03	160.04	120.65	94.71	35.67
Net Income Growth	46.28%	41.23%	32.66%	27.38%	165.51%	-
Shares Outstanding (Basic)	403	353	341	335	306	51
Shares Outstanding (Diluted)	403	353	341	335	306	51
Shares Change (YoY)	19.70%	3.71%	1.61%	9.69%	499.54%	-
EPS (Basic)	0.76	0.64	0.47	0.36	0.31	0.70
EPS (Diluted)	0.76	0.64	0.47	0.36	0.31	0.70
EPS Growth	22.21%	36.17%	30.56%	16.13%	-55.71%	-
Free Cash Flow	194.22	238.87	124.67	-13.38	28.93	43.42
Free Cash Flow Per Share	0.48	0.68	0.37	-0.04	0.10	0.85
Dividend Per Share	0.350	0.170	-	-	-	-
Gross Margin	57.96%	56.11%	54.06%	52.63%	52.35%	53.45%
Operating Margin	24.09%	23.49%	20.71%	22.43%	24.13%	16.76%
Profit Margin	24.55%	21.88%	18.70%	20.72%	21.39%	12.80%
Free Cash Flow Margin	15.58%	23.13%	14.56%	-2.30%	6.53%	15.58%
EBITDA	321.7	262.23	194.59	138.59	114.84	54.71
EBITDA Margin	25.80%	25.39%	22.73%	23.81%	25.93%	19.63%
D&A For EBITDA	21.37	19.6	17.25	8.01	8.01	8.01
EBIT	300.33	242.62	177.34	130.58	106.84	46.7
EBIT Margin	24.09%	23.49%	20.71%	22.43%	24.13%	16.76%
Effective Tax Rate	13.70%	15.64%	14.99%	14.82%	14.09%	14.54%
Revenue as Reported	1,247	1,033	856.09	582.15	442.83	278.64
Advertising Expenses	-	218.47	187.47	107.9	77.12	40.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.